Masimo (MASI) Tops Q2 Earnings and Revenue Estimates
Masimo (MASI) came out with quarterly earnings of $0.86 per share, beating the Zacks Consensus Estimate of $0.77 per share. This compares to earnings of $0.62 per share a year ago.
Reasons to Add Masimo (MASI) Stock to Your Portfolio Now
Masimo's (MASI) R&D activities raise optimism about the stock.
Masimo (MASI) Sues Politan for Misstatements, Delays Annual Meet
Masimo (MASI) sues Politan to correct material misstatements in an ongoing proxy battle, rescheduling its annual meeting. Politan denies allegations and vows to prevent any further delay, criticizing Masimo's tactics.
Masimo initiates legal action against activist investor Politan
Medical device maker Masimo Corp on Tuesday said it has started litigation against Politan Capital in a California federal court, seeking to force the activist investor to correct "material misstatements and omissions" in its proxy materials.
Proxy advisor ISS says Masimo change is 'absolutely necessary' in brutal report
Proxy advisor Institutional Shareholder Services said boardroom change at medical technology company Masimo was "absolutely necessary." The unusually sharp report, a copy of which was viewed by CNBC, said shareholders should vote for activist Politan Capital Management's board nominees, Bill Jellison and Darlene Solomon.
Proxy advisor backs activist Politan nominees in scathing Masimo report
Proxy advisory firm Glass Lewis said Masimo shareholders should vote for activist Politan nominees Darlene Solomon and Bill Jellison. The advisory firm said that Masimo CEO Joe Kiani ran "roughshod" over his "self-selected board," echoing concerns from the activist and some analysts.
Masimo (MASI) Gets Non-Binding Offer for Consumer Business
Masimo (MASI) gets an acquisition offer for its consumer business from an undisclosed entity. The deal is likely to close later in 2024.
Masimo (MASI) Preliminary Q2 Results Aided by Healthcare Unit
Masimo's (MASI) second-quarter 2024 results are likely to reflect the strength in the Healthcare business.
Masimo receives offer of up to $950 mln for consumer business
Masimo said on Monday a potential joint venture partner is prepared to offer $850 million to $950 million for its consumer business, which includes health and audio products.
Masimo (MASI) Fights Politan in a Bid to Retain CEO on Board
Will Masimo (MASI) lose its CEO in its fight against activist investor Politan Capital Management? The company's management and employees want Joe Kiani to continue as the CEO.
Masimo's (MASI) WI Sport Wearable Gets a New Powerful Feature
Masimo (MASI) announces Sleep Halo, a new feature for its Masimo W1 Sport advanced health tracking wearable.
Masimo COO Muhsin to resign if activist investor Politan takes control
Masimo Chief Operating Officer Bilal Muhsin has told the board he would resign if activist investor Politan Capital Management takes control of the company and CEO Joe Kiani is removed, according to a regulatory filing.
